M&T Bank Corp Lannett CO Inc Transaction History

M&T Bank Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$3.43 - $6.19 $34,464 - $62,197	-10,048 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$4.75 - $14.5 $189,919 - $579,753	-39,983 Reduced 79.92%	10,048 $48,000
Q2 2018 Aug 10, 2018	SELL	$13.3 - $17.45 $1,117 - $1,465	-84 Reduced 0.17%	50,031 $680,000
Q1 2018 May 04, 2018	SELL	$14.7 - $24.95 $9,687 - $16,442	-659 Reduced 1.3%	50,115 $804,000
Q4 2017 Feb 06, 2018	BUY	$19.9 - $29.25 $1,472 - $2,164	74 Added 0.15%	50,774 $1.18 Million
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $765,570 - $975,975	50,700	50,700 $935,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.